Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for Diabetic Neuropathy Treatment is witnessing a full-size surge because of the escalating prevalence of diabetes globally. With diabetes turning into a large health difficulty, the prevalence of Diabetic Neuropathy, a commonplace trouble, is also on the upward thrust. With ache being a primary symptom of Diabetic Neuropathy, there's a growing demand for effective ache management solutions. Analgesic pills, topical treatments, and nerve pain medicines are gaining traction within the market as patients are looking for alleviation from neuropathic aches related to diabetes. The Diabetic Neuropathy Treatment market is regularly shifting towards personalized medicine methods. Tailoring treatment plans primarily based on male or female patient traits, genetic factors, and response to remedies is gaining prominence. This trend reflects a growing knowledge of the heterogeneity of Diabetic Neuropathy and the want for custom-designed remedy strategies.
Complementary and opportunity remedies, inclusive of physical therapy, acupuncture, and lifestyle changes, are gaining attention in the Diabetic Neuropathy Treatment landscape. These non-pharmacological interventions aim to complement conventional scientific tactics, supplying holistic care and enhancing standard patient consequences. Research collaborations among pharmaceutical companies, instructional establishments, and healthcare corporations are fostering innovation in Diabetic Neuropathy Treatment. Such partnerships facilitate the pooling of resources, know-how, and statistics, accelerating the development of novel therapeutic processes and bringing them to market extra successfully. Recognizing the importance of early detection and control, there is a developing emphasis on patient training and consciousness programs. These initiatives goal to empower people with diabetes to proactively manage their condition, lessen the threat of growing neuropathy, and search for timely medical intervention while essential.
The Diabetic Neuropathy Treatment market is experiencing global growth, driven by using multiplied focus, improved healthcare infrastructure, and growing disposable incomes in rising economies. This widening geographic footprint provides possibilities for market players to tap into new patient populations and cope with numerous healthcare needs. Stringent regulatory frameworks and hints are shaping the Diabetic Neuropathy Treatment market. The approval methods for new capsules and healing procedures, in conjunction with adherence to protection and efficacy standards, are important elements influencing market dynamics. Keeping abreast of regulatory tendencies is critical for industry stakeholders to navigate this evolving landscape.
Diabetic Neuropathy Treatment Market Highlights:
Global Diabetic Neuropathy Treatment Market Overview
Diabetic Neuropathy Treatment Market Size was valued at USD 4.44 Billion in 2023. The Global Diabetic Neuropathy Treatment industry is projected to grow from USD 5.22 Billion in 2024 to USD 9.53 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.91% during the forecast period (2024 - 2032).
The number of diabetic neuropathy cases is increasing globally, fueling market growth. Diabetic neuropathy treatment is the second-highest contributor to global disability and an estimated 30% to 40% of people across the globe live with diabetic neuropathy.
Diabetic neuropathy is most common in low- and middle-income countries, and this disorder requires lifelong care to manage.
Latest Industry Developments in Diabetic Neuropathy Treatment Market
July 2024,Abbott has launched a new, advanced continuous glucose monitoring system with improved algorithms, aimed at improving glucose control and managing diabetic neuropathy more effectively.
May 2024,Pfizer has introduced a new gene therapy method for diabetic neuropathy, utilizing advanced gene editing techniques to repair nerve damage and enhance sensory function in diabetic patients.
Market Influencer
The rising prevalence of diabetic disorders and increasing reimbursement offered to patients by health insurance providers.
Market Drivers
- Growing global geriatric population.
- Change in lifestyle habits leading to bad posture, which is increasing the prevalence of diabetic neuropathy disorder.
- Increasing research and development of new drugs to treat diabetic neuropathy disorder.
- Rising prevalence of diabetic neuropathy. For example, the prevalence of diabetic neuropathy in the fiscal year 2000 to 2030 will reach up to 366 million people in the US.
- Rising awareness of advanced treatments for diabetic neuropathy.
- Launch of a new medication to manage the symptoms of chronic diabetic neuropathy.
Market Restraints
- High treatment costs.
- Availability of alternative therapies such as traditional medicine and physiotherapy.
- Need for specialized equipment to diagnose and treat diabetic neuropathy.
Diabetic Neuropathy Treatment Market Segmentation
Diabetic Neuropathy Treatment Disorder Insights
- Peripheral Neuropathy: The largest segment of the market, peripheral neuropathy afflicts almost 1% of the entire global population and is three times as likely to afflict women than men.
- Autonomic Neuropathy: This disorder generally afflicts elderly people. As of 2018, about 23 million people in the US had autonomic neuropathy and over a quarter of those afflicted could not perform daily activities.
- Proximal Neuropathy: It is a rare type of nerve damage that occurs in hip, buttock, or thigh. It typically affects one side of the body and rarely spreads to the other side of the body. About 50% of patients suffering from diabetes have proximal neuropathy.
- Focal Neuropathy: This focal neuropathy disorder afflicts roughly 3 out of every ten individuals who have diabetes with over 100 million people affected globally.
Diabetic Neuropathy Treatment Insights
- Drugs: The fastest-growing segment of the market, drugs are most widely used for the treatment of diabetic neuropathy. A rise in the number of FDA approvals for drugs to treat diabetic neuropathy is a key factor for the growth of the segment.
- Transcutaneous Electrical Nerve Stimulation (TENS): The largest segment, TENS is the preferred treatment for many diabetic neuropathies as they reduce inflammation and suppress immune system activity.
- Others: The other segment includes physiotherapy and electroacupuncture and various other treatment options for diabetic neuropathy.
Diabetic Neuropathy Treatment End-User Insights
- Hospitals and Clinics: The largest segment, hospitals, and clinics are usually the primary points for diagnosis, treatment, and rehabilitation of individuals afflicted with diabetic neuropathy. Growing awareness and increasing efficiency of diabetic neuropathy treatment are projected to drive the growth of this segment during the forecast period.
- Retail Pharmacy: A small segment. This center provides immediate pain relief and rudimentary drugs for diabetic neuropathy.
- Online Pharmacy: Various drugs are used for the treatment of diabetic neuropathy which can be easily available in online pharmacy.
- Others: This segment includes home care and senior citizen centers.
Diabetic Neuropathy Treatment Regional Insights
- Americas: The largest regional market. The prevalence of diabetic neuropathy is high in the Americas. The region also has a well-established healthcare industry. Out of the entire population, around 72.2% people in the US were suffering from diabetic neuropathy.
- Europe: An increasing geriatric population is leading to a rise in the number of diabetic neuropathy disorder cases.
- Asia-Pacific: The fastest-growing regional market. Asia-Pacific is seeing a surge in the number of people afflicted with diabetic neuropathy due to bad posture brought on by lifestyle changes, aging, and genetic predisposition. Diabetic neuropathy is an increasing problem in Asia. Approximately 4000 patients were diagnosed with diabetic neuropathy in Korea, whereas in Japan, around 298 people were diagnosed with diabetic neuropathy.
- Middle East & Africa: The smallest market due to limited healthcare infrastructure and a very young population.
Diabetic Neuropathy Treatment Market Top Key Players
- Abbott Laboratories (US)
- Hoffmann-La Roche Ltd (Switzerland)
- Eli Lilly and Company (US)
- Johnson & Johnson (US)
- GlaxoSmithKline Plc (UK)
- Lupin Limited (India)
- Glenmark Pharmaceuticals Limited (India)
- Depomed, Inc. (US)
- Astellas Pharma Inc (Japan)
- Pfizer Inc (US)
- MEDA Pharma GmBH & Co. KG (Germany)
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
